To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Platelet-Rich Plasma Versus Alternative Injections for Osteoarthritis of the Knee Pain & Function

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2025

Platelet-Rich Plasma Versus Alternative Injections for Osteoarthritis of the Knee Pain & Function

Vol: 307| Issue: 1| Number:52| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Platelet-Rich Plasma Versus Alternative Injections for Osteoarthritis of the Knee: A Systematic Review and Statistical Fragility Index-Based Meta-analysis of Randomized Controlled Trials.

Am J Sports Med . 2024 Oct;52(12):3147-3160.

Contributing Authors:
JF Oeding NH Varady FW Fearington A Pareek SM Strickland BU Nwachukwu CL Camp AJ Krych

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

This systematic review and meta-analysis included 16 randomized controlled trials (RCTs) with a total of 1,993 patients with knee osteoarthritis. The study compared the effects of platelet-rich plasma (PRP) injections versus various nonoperative treatments, including hyaluronic acid (HA), corticosteroids, and saline. Pooled outcomes of interest were patient-reported symptom relief, pain improvemen...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue